臺灣健保癌症用藥事前審查實作指引
1.0.8 - ci-build

臺灣健保癌症用藥事前審查實作指引, published by 衛生福利部中央健康保險署. This guide is not an authorized publication; it is the continuous build for version 1.0.8 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/TWNHIFHIR/pas/ and changes regularly. See the Directory of published versions

CodeSystem: INCa-健保事前審查-基因突變類型

Official URL: https://nhicore.nhi.gov.tw/pas/CodeSystem/inca-osiris Version: 1.0.8
Active as of 2025-09-01 Computable Name: INCaOsiris

INCa-健保事前審查-基因突變類型,資料所屬單位:Institut National du Cancer (INCa),參照至:https://github.com/InstitutNationalduCancer/OSIRIS。

This Code system is referenced in the content logical definition of the following value sets:

This case-sensitive code system https://nhicore.nhi.gov.tw/pas/CodeSystem/inca-osiris defines the following code:

CodeDisplay
O55-2 Delins